People · Operator
Named in public records as an officer, director or promoter · active 2006–2025 · Pharmaceuticals, Retailing, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rivus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $223.5M | $415.9M | 2022 |
| Solid Biosciences Inc. | — | Pharmaceuticals | Series C | $109.2M | $139.2M | 2020 |
| CarGurus, Inc. | — | Retailing | Seed | $3.1M | $8.8M | 2006 |
| Funky Eyes International, Inc. | — | Manufacturing | Pre-Seed | $600K | $9.2M | 2014 |
Ian Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ian Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Parker | 1 | 11 |
| Patrick Enright | 1 | 10 |
| Derek DiRocco | 1 | 7 |
| Anastasios Parafestas | 1 | 5 |
| Adam Stone | 1 | 5 |
| Francesco De Rubertis | 1 | 4 |
| Simon Rothman | 1 | 4 |
| Rajeev Shah | 1 | 4 |
| Matthew Arnold | 1 | 4 |
| Lynne Sullivan | 1 | 3 |
| Ilan Ganot | 1 | 3 |
| Jason Trevisan | 1 | 3 |
| Erin Lavelle | 1 | 3 |
| Adam Koppel | 1 | 3 |
| Martin Freed | 1 | 3 |
| Jayson Dallas | 1 | 2 |
| Langley Steinert | 1 | 2 |
| David Tyronne Howton | 1 | 2 |
| Stephen Kaufer | 1 | 2 |
| Stephen DiPalma | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.